Back
Relay Therapeutics Stock Price Chart
Sell
36
RLAY
Relay Therapeutics
Last Price:
6.64
Seasonality Move:
11.86%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLAY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Relay Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.5 | Buy |
| 20-day SMA: | 6.52 | Buy |
| 50-day SMA: | 7.19 | Sell |
| 200-day SMA: | 8.85 | Sell |
| 8-day EMA: | 6.57 | Buy |
| 20-day EMA: | 6.64 | Sell |
| 50-day EMA: | 7.26 | Sell |
| 200-day EMA: | 9.37 | Sell |
Relay Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 47.68 | Sell |
| Chaikin Money Flow: | 889160 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.16 - 6.82) | Buy |
| Bollinger Bands (100): | (6.94 - 10.56) | Sell |
Relay Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Relay Therapeutics Stock
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 6.64 while RLAY 8-day simple moving average is 6.50, which is a Buy signal.
- The stock price of RLAY is 6.64 while Relay Therapeutics 20-day SMA is 6.52, which makes it a Buy.
- Relay Therapeutics 50-day simple moving average is 7.19 while RLAY share price is 6.64, making it a Sell technically.
- RLAY stock price is 6.64 and Relay Therapeutics 200-day simple moving average is 8.85, creating a Sell signal.
RLAY Technical Analysis vs Fundamental Analysis
Sell
36
Relay Therapeutics (RLAY)
is a Sell
Is Relay Therapeutics a Buy or a Sell?
-
Relay Therapeutics stock is rated a Sell
The current Relay Therapeutics [RLAY] share price is $6.64. The Score for RLAY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Relay Therapeutics Stock Info
Market Cap:
881.4M
Price in USD:
6.64
Share Volume:
1.51M
Relay Therapeutics 52-Week Range
52-Week High:
13.32
52-Week Low:
5.70
Sell
36
Relay Therapeutics (RLAY)
is a Sell
Relay Therapeutics Share Price Forecast
-
What is the Relay Therapeutics stock price today?
The Relay Therapeutics stock price is 6.64 USD today. -
Will RLAY stock go up or go down?
Relay Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Relay Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relay Therapeutics is overvalued.
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 6.64 while RLAY 8-day exponential moving average is 6.57, which is a Buy signal.
- The stock price of RLAY is 6.64 while Relay Therapeutics 20-day EMA is 6.64, which makes it a Sell.
- Relay Therapeutics 50-day exponential moving average is 7.26 while RLAY share price is 6.64, making it a Sell technically.
- RLAY stock price is 6.64 and Relay Therapeutics 200-day simple moving average is 9.37, creating a Sell signal.
Fundamental Analysis of Relay Therapeutics
Is Relay Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.02 per share, an increase this year of $0.09 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Relay Therapeutics
Should I short Relay Therapeutics stock?
- RLAY Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Relay Therapeutics is a Sell
- Relay Therapeutics Relative Strength Index (RSI) is 47.68, which suggest Relay Therapeutics is oversold
- The Bollinger Bands (25) for Relay Therapeutics is (6.16 - 6.82), which suggest Relay Therapeutics is a Sell
- The Bollinger Bands (100) for Relay Therapeutics is (6.94 - 10.56), which suggest Relay Therapeutics is a Sell
* Relay Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.